Clinical Trial Update: Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of azacitidine, valproic acid, and carboplatin in patients with ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• CARBOPLATIN (Carboplatin)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Solid Tumors | Phase 1 | Status: COMPLETED